Sunny Reddy

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat life-threatening diseases.

Raised $134,000,000.00 from Northpond Ventures, Alexandria Venture Investments, Sectoral Asset Management, Cormorant Asset Management, OrbiMed, Mass General Brigham Ventures and Aisling Capital.

Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies

Raised $172,000,000.00 from Intermediate Capital Group, Alexandria Venture Investments, Lightchain, Aisling Capital, Fidelity, Alpha Wave Global, LYZZ Capital, Abingworth, Tybourne Capital Management and Velosity Capital.

Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.

Raised $330,000,000.00 from Drive Capital and Aisling Capital.